Management of acute promyelocytic leukemia in the elderly.

about

Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia.

P2860

Q42720957-6C174546-88FE-44DA-8437-D772FD11E60B

P2860

Management of acute promyelocytic leukemia in the elderly.

Item

http://www.wikidata.org/entity/Q39368616

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Management of acute promyelocytic leukemia in the elderly.

@en

Management of acute promyelocytic leukemia in the elderly.

@nl

type

Item

label

Management of acute promyelocytic leukemia in the elderly.

@en

Management of acute promyelocytic leukemia in the elderly.

@nl

prefLabel

Management of acute promyelocytic leukemia in the elderly.

@en

Management of acute promyelocytic leukemia in the elderly.

@nl

P1476

Management of acute promyelocytic leukemia in the elderly.

@en

P2860

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

All-trans-retinoic acid in acute promyelocytic leukemia

Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia.

How I treat acute promyelocytic leukemia.

The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease.

Acute promyelocytic leukemia: evolving therapeutic strategies.

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

P304

e2013045

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4084/MJHID.2013.045

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Latagliata

Massimo Breccia

Francesco Lo-Coco

P577

2013-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23936616

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

3736876

http://www.w3.org/2001/XMLSchema#string

Management of acute promyelocytic leukemia in the elderly.

about

P2860

P2860

Management of acute promyelocytic leukemia in the elderly.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932